Mangoceuticals, Inc. (MGRX)

Mangoceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.1	0.06	0.74	0.68	0.02
Cash & Short-Term Investments	0.1	0.06	0.74	0.68	0.02
Cash Growth	-79.39%	-92.06%	8.22%	2928.20%	-
Inventory	-	-	0.02	-	-
Prepaid Expenses	-	-	-	0.01	-
Other Current Assets	0.02	0.02	0.08	-	-
Total Current Assets	0.12	0.08	0.84	0.69	0.02
Property, Plant & Equipment	0.03	0.18	0.22	0.29	-
Other Intangible Assets	20.69	15.23	-	-	-
Other Long-Term Assets	-	-0.12	-	0.02	-
Total Assets	20.84	15.37	1.05	1	0.02
Accounts Payable	0.77	0.84	0.14	0.03	-
Accrued Expenses	0.03	-	0.01	0	-
Short-Term Debt	0.6	0.15	-	0.17	0.04
Current Portion of Leases	0.03	0.06	0.06	0.06	-
Other Current Liabilities	0.17	0.37	-	-	-
Total Current Liabilities	1.6	1.43	0.21	0.26	0.04
Long-Term Leases	-	-	0.06	0.13	-
Total Liabilities	1.6	1.43	0.28	0.39	0.04
Common Stock	0	0	0	0	0
Additional Paid-In Capital	50.79	35.59	12	2.63	0
Retained Earnings	-31.65	-20.81	-11.23	-2.02	-0.02
Comprehensive Income & Other	0.1	-0.84	-	-	-
Total Common Equity	19.24	13.95	0.77	0.61	-0.02
Minority Interest	-0	-0	-	-	-
Shareholders' Equity	19.24	13.95	0.77	0.61	-0.02
Total Liabilities & Equity	20.84	15.37	1.05	1	0.02
Total Debt	0.63	0.21	0.13	0.35	0.04
Net Cash (Debt)	-0.53	-0.16	0.61	0.33	-0.02
Net Cash Growth	-	-	84.95%	-	-
Net Cash Per Share	-0.11	-0.08	0.57	0.46	-0.03
Filing Date Shares Outstanding	10.54	5.17	1.53	0.89	0.53
Total Common Shares Outstanding	10.64	3.25	1.43	0.89	0.53
Working Capital	-1.48	-1.35	0.62	0.43	-0.02
Book Value Per Share	1.81	4.30	0.54	0.69	-0.03
Tangible Book Value	-1.45	-1.29	0.77	0.61	-0.02
Tangible Book Value Per Share	-0.14	-0.40	0.54	0.69	-0.03
Machinery	0.01	0.12	0.12	0.12	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q